Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
- PMID: 30090744
- PMCID: PMC6057165
- DOI: 10.4103/ajm.AJM_21_18
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
Abstract
The high incidence and recurrence rate of breast cancer has influenced multiple strategies such as early detection with imaging, chemoprevention and surgical interventions that serve as preventive measures for women at high risk. Prophylactic mastectomy is one of the growing strategies of breast cancer risk reduction that is of a special importance for breast cancer gene mutation carriers. Women with personal history of cancerous breast lesions may consider ipsilateral or contralateral mastectomy as well. Existing data showed that mastectomy effectively reduces breast cancer risk. However, careful risk estimation is necessary to wisely select individuals who will benefit from preventing breast cancer.
Keywords: BRCA; breast neoplasms; ductal carcinoma in situ; prophylactic mastectomy; risk reduction.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.Ann Ital Chir. 2019;90:1-2. Ann Ital Chir. 2019. PMID: 30872561
-
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352. Cancer. 2006. PMID: 17109443
-
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Gynecol Oncol. 2017 May;145(2):346-351. doi: 10.1016/j.ygyno.2017.02.032. Epub 2017 Mar 14. Gynecol Oncol. 2017. PMID: 28314588
-
Breast cancer treatment in mutation carriers: surgical treatment.Minerva Ginecol. 2016 Oct;68(5):548-56. Epub 2016 Jan 28. Minerva Ginecol. 2016. PMID: 26822896 Review.
-
Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.Prescrire Int. 2013 Dec;22(144):298-303. Prescrire Int. 2013. PMID: 24600734 Review.
Cited by
-
Implant-based Breast Reconstruction after Mastectomy for Breast Cancer: A Systematic Review and Meta-analysis.Plast Reconstr Surg Glob Open. 2022 Mar 18;10(3):e4179. doi: 10.1097/GOX.0000000000004179. eCollection 2022 Mar. Plast Reconstr Surg Glob Open. 2022. PMID: 35317462 Free PMC article.
-
Advancing DIEP Flap Surgery: Robotic-Assisted Harvest Reduces Pain and Narcotic Use.J Clin Med. 2025 Jul 23;14(15):5204. doi: 10.3390/jcm14155204. J Clin Med. 2025. PMID: 40806826 Free PMC article.
-
Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Breast. 2023 Feb;67:30-35. doi: 10.1016/j.breast.2022.12.001. Epub 2022 Dec 6. Breast. 2023. PMID: 36577271 Free PMC article.
-
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.Int J Cancer. 2021 May 1;148(9):2289-2303. doi: 10.1002/ijc.33417. Epub 2020 Dec 16. Int J Cancer. 2021. PMID: 33252836 Free PMC article.
-
Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.Ann Surg Oncol. 2020 Nov;27(12):4613-4621. doi: 10.1245/s10434-020-08889-6. Epub 2020 Jul 27. Ann Surg Oncol. 2020. PMID: 32720048 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. - PubMed
-
- SEER Cancer Statistics Review 1975-2014. National Cancer Institute. [Last accessed on 2017 Oct 09]. Available from: https://www.seer.cancer.gov/csr/1975_2014/results_merged/sect_04_breast.pdf .
-
- Ghosh K, Hartmann LC. Current status of prophylactic mastectomy. Oncology (Williston Park) 2002;16:1319–25. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources